GLP-1 drugs, including Zepbound and Wegovy, are being considered for weight loss treatment, with some outlets comparing their effectiveness. Medicare is set to begin covering weight loss drugs, although details of the coverage are not entirely clear. The use of GLP-1 medications for weight loss is a developing area, with various health organizations and medical centers providing information on their safety, side effects, and usage.